What The Amedisys Divestment Snag Means For The Home Health Industry

As UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) work on a divestment strategy that will satisfy regulators, a lot hangs in the balance. For one, UnitedHealth Group and Optum’s deal for the home health and hospice provider Amedisys is one of the largest deals in the industry’s history, only trailing Optum’s deal for Amedisys’ […]

Private Equity-Backed Buyer Drops Out Of Sweepstakes For Divested Amedisys Locations

In early May, it was reported that UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) were working on a divestment package to satisfy regulator concerns over antitrust violations. Capitol Forum had previously reported that Amedisys was aiming to offload more than 100 of its locations to a “private equity-backed buyer.” On Friday, Capitol Forum reported […]

Report: Amedisys-UnitedHealth Group Closing In On Sizable Divestment Package

A new report claims that home health giant Amedisys Inc. (Nasdaq: AMED) and UnitedHealth Group (NYSE: UNH) are closing in on a sizable divestment package to help circumvent antitrust concerns from regulators. UnitedHealth Group and its Optum arm announced a $3.3 billion deal to acquire Baton Rouge, Louisiana-based Amedisys last year, luring the in-home care […]

Amedisys Continues To Drive Growth In Home Health, High-Acuity Care Segments

While waiting for UnitedHealth Group’s (NYSE: UNH) purchase of it to finalize, Amedisys Inc. (Nasdaq: AMED) continues to grow its home health segment – primarily through non-Medicare revenue – and its higher-acuity care segment. The company reported its first-quarter earnings late Wednesday, which showed a 10% increase in total same store admissions in home health […]

UnitedHealth Group Remains Under Duress From Change Healthcare Cyberattack, DOJ Investigation

It was a turbulent start to the year for the health care giant UnitedHealth Group, driven by the cyberattack on Change Healthcare and a U.S. Department of Justice (DOJ) antitrust investigation. Amid the DOJ investigation, UnitedHealth Group’s planned acquisition of the home health company Amedisys Inc. (Nasdaq: AMED) came into focus, with reports circulating that […]

Exploring What An Amedisys Divestment Strategy Could Look Like

UnitedHealth Group (NYSE: UNH) and Amedisys Inc. (Nasdaq: AMED) announced combination plans last June, under which home health giant Amedisys would become part of Optum. Amedisys had previously entered into an agreement to merge with infusion therapy company Option Care Health (Nasdaq: OPCH), but UnitedHealth Group’s offer, scale and complementary clinical capabilities were effectively too […]

The Most Game-Changing Home-Based Care Blockbusters Of The Last Decade

Thanks to impactful, large-scale transactions over the last decade, the collective face of home-based care has changed forever. Traditional providers in both home health care and personal home care have merged. Payers became involved in the home-based care space like never before. Of late, retailers have too. But it’s often easy to forget how the […]

DOJ Reportedly Considering Lawsuit To Block Optum-Amedisys Deal

UnitedHealth Group’s (NYSE:UNH) planned acquisition of Amedisys Inc. (Nasdaq:AMED) is catching further scrutiny. Late Wednesday, a report suggesting that the Department of Justice is considering a lawsuit to block Optum’s takeover of Amedisys surfaced. The deal was first agreed to in June of last year. The news comes just a few weeks after the DOJ […]